Revvity Inc.
RVTY Healthcare Diagnostics & Research
Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow RVTY
Revvity Inc. (RVTY) Book value per share
Revvity Inc.'s book value per share at the end of fiscal 2025 was 62.2×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 64.8×. Over the past ten years it has ranged from 18.8× (fiscal 2015) to 63.1× (fiscal 2023); the current reading is higher than 82% of that period. Revvity Inc. ranks 7th of 52 Diagnostics & Research companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 62.2× | (0.39%) |
| FY2024 | 62.5× | (1.07%) |
| FY2023 | 63.1× | 7.88% |
| FY2022 | 58.5× | (4.80%) |
| FY2021 | 61.5× | 83.52% |
| FY2020 | 33.5× | 31.94% |
| FY2019 | 25.4× | 8.59% |
| FY2018 | 23.4× | 2.61% |
| FY2017 | 22.8× | 15.83% |
| FY2016 | 19.7× | 4.87% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 64.8× | 0.88% |
| Mar 2026 | 64.2× | 3.22% |
| Dec 2025 | 62.2× | (2.66%) |
| Sep 2025 | 63.9× | (0.61%) |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| ICLR ICON PLC compare | 122× |
| LH Labcorp Holdings Inc. compare | 105× |
| DGX Quest Diagnostics Incorporated compare | 70.4× |
| RVTY Revvity Inc. | 64.8× |
| CRL Charles River Laboratories International, Inc. compare | 59.3× |
| QGEN QIAGEN N.V. compare | 16.3× |
| MEDP Medpace Holdings, Inc. compare | 15.4× |
| TWST Twist Bioscience Corporation compare | 7.1× |
| GH Guardant Health, Inc. compare | −1.7× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on RVTY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement